Selectively targeting estrogen receptors for cancer treatment
- 10 August 2010
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 62 (13) , 1265-1276
- https://doi.org/10.1016/j.addr.2010.08.001
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- Blocking Estrogen Signaling After the Hormone: Pyrimidine-Core Inhibitors of Estrogen Receptor-Coactivator BindingJournal of Medicinal Chemistry, 2008
- Amphipathic Benzenes Are Designed Inhibitors of the Estrogen Receptor α/Steroid Receptor Coactivator InteractionACS Chemical Biology, 2008
- Evaluation of synthetic isoflavones on cell proliferation, estrogen receptor binding affinity, and apoptosis in human breast cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2008
- Liquiritigenin is a plant-derived highly selective estrogen receptor β agonistMolecular and Cellular Endocrinology, 2007
- The role of estrogens and estrogen receptors in normal prostate growth and diseasePublished by Elsevier ,2007
- Estrogen Receptor β Inhibits Angiogenesis and Growth of T47D Breast Cancer XenograftsCancer Research, 2006
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Transcriptional Profiling of Estrogen-Regulated Gene Expression via Estrogen Receptor (ER) α or ERβ in Human Osteosarcoma Cells: Distinct and Common Target Genes for These ReceptorsEndocrinology, 2004
- Involvement of estrogen receptor β in terminal differentiation of mammary gland epitheliumProceedings of the National Academy of Sciences, 2002
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997